跳至主要内容
临床试验/NCT02775734
NCT02775734已完成2 期

N-acetyl-cysteine in Clomiphene Citrate Resistant Polycystic Ovary Syndrome After Laparoscopic Ovarian Drilling: A Randomized Controlled Trial

Ain Shams University1 个研究点 分布在 1 个国家目标入组 144 人开始时间: 2016年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
144
试验地点
1
主要终点
Biochemical pregnancy rate

研究概览

简要总结

This prospective randomized placebo-controlled double blind clinical trial will conducted in Ain Shams University maternity Hospital including 120 women diagnosed with clomiphene citrate resistant polycystic ovary syndrome. After laparoscopic ovarian drilling, they will be randomized to either receiving 50 mg oral clomiphene citrate twice daily and oral NAC 1,200 mg/day for 5 days starting from cycle day 2 to cycle day 6 (group 1 = 60 patients) or clomiphene citrate only (group 2 = 60 patients). The primary outcome will be biochemical pregnancy rate, secondary outcomes include Clinical pregnancy rate, ovulation rate, live birth rate, number of follicles ≥ 18 mm and endometrial thickness at triggering ovulation, mid- luteal sub-endometrial blood flow indices, and incidence of side effects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Body mass index (BMI) between 25 and 30 Kg/m
  • CC-resistant Polycystic ovary syndrome

排除标准

  • • Patients with BMI under 25 or over 30 Kg/m
  • Hyper or hypothyroidism, or hyperprolactinemia.
  • Current or previous (within the last six months) use of oral contraceptives, glucocorticoids, antiandrogens, antidiabetic and anti-obesity drugs or other hormonal drugs.
  • Intention to start a diet or a specific program of physical activity.
  • Organic pelvic diseases.
  • Tubal or male factor infertility.
  • Interval of earlier treatment with any of the fertility drugs of less than 6 months.
  • Contraindication to either:
  • Clomiphene citrate: liver disease, undiagnosed abnormal uterine bleeding, uterine fibroids, endometrial cancer, ovarian enlargement or hyper stimulation
  • HCG injection: ovarian enlargement or hyper stimulation

研究组 & 干预措施

N-acetyl-cysteine

Active Comparator

N-acetyl-cysteine + Clomiphene citrate + LOD

干预措施: N-acetyl-cysteine (Drug)

N-acetyl-cysteine

Active Comparator

N-acetyl-cysteine + Clomiphene citrate + LOD

干预措施: Clomiphene citrate (Drug)

NO N-acetyl-cysteine

Active Comparator

Clomiphene citrate + LOD

干预措施: Clomiphene citrate (Drug)

结局指标

主要结局

Biochemical pregnancy rate

时间窗: 6 months

次要结局

  • follicles more than or equal 18 mm(6 months)
  • Pre-ovulatory endometrial thickness(6 months)
  • Clinical pregnancy rate(6 months)
  • Ovulation rate(6 months)
  • Live-birth rate(15 months)
  • Incidence of side effects(6 months)
  • mid-luteal sub-endometrial doppler blood flow indices(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohamed S Sweed, MD

Dr

Ain Shams University

研究点 (1)

Loading locations...

相似试验